REG - Alliance Pharma PLC - Notification of Major Holdings
RNS Number : 6104AAlliance Pharma PLC22 January 2020TR-1: Standard form for notification of major holdings
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Alliance Pharma Plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Details of person subject to the notification obligation
Name
MVM Partners LLP
City and country of registered office (if applicable)
London, UK
4. Full name of shareholder(s) (if different from 3.)
Name
MVM Fund III LP, MVM Fund III (no 2) LP
City and country of registered office (if applicable)
London, UK
5. Date on which the threshold was crossed or reached:
17/01/2020
6. Date on which issuer notified (DD/MM/YYYY):
22/01/2020
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)
% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)
Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached
5.8%
5.8%
529,402,619
Position of previous notification (if
applicable)
6.9%
6.9%
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
A: Voting rights attached to shares
Class/type of
sharesISIN code (if possible)
Number of voting rights
% of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0031030819
30,535,598
5.8%
SUBTOTAL 8. A
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument
Expiration
dateExercise/
Conversion PeriodNumber of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument
Expiration
dateExercise/
Conversion PeriodPhysical or cash
settlement
Number of voting rights
% of voting rights
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)
Name
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information
Place of completion
London, UK
Date of completion
22nd January 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDHOLBTMTTMTMTBTM
Recent news on Alliance Pharma
See all newsREG - Alliance Pharma PLC - Notification of Half Year Results
AnnouncementREG - Alliance Pharma PLC - Result of AGM
AnnouncementREG - Alliance Pharma PLC - Half Year Trading Update
AnnouncementREG - Alliance Pharma PLC - Notification of Major Holdings
AnnouncementREG - Alliance Pharma PLC - Notification of Major Holdings
Announcement